|
Therapeutic effect of enhanced exetrnal counterpulsation therapy in elderly patients with chronic heart failure and renal insufficiency
OU Dongbo, WANG Qi, FENG Guangqin, LI Wei, HUANG Xiaolian, WEI Li
2024, 38 (11):
1131-1135.
doi: 10.3969/j.issn.1003-9198.2024.11.011
Objective To explore the therapeutic effect of enhanced exetrnal counterpulsation (EECP) therapy in the elderly patients with chronic heart failure and renal insufficiency. Methods A total of 90 patients with chronic heart failure and renal insufficiency who were hospitalized in Jiangbin Hospital of Guangxi Zhuang Autonomous Region were randomly divided into the counterpulsation group and the control group, with 45 patients in each group. The control group received conventional internal medicine treatment, while the counterpulsation group received EECP on the basis of conventional treatment. The levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) cardiac function classification, serum creatinine (Scr), 24-hour urine output, maximal oxygen uptake (VO2max), anaerobic threshold (AT) and activities of daily living (ADL) were recorded and compared between the two groups before and after treatment. Results Finally, there were 40 patients finished the treatment in each group. Before treatment, there were no significant differences in the levels of NT-proBNP, LVEF, NYHA classification, Scr, 24-hour urine output, VO2max, AT and ADL between the two groups (P>0.05). After 18 days of treatment, the levels of NT-proBNP, NYHA classification, Scr, 24-hour urine output in the two groups and the levels of VO2max and AT in the counterpulsation group were significantly improved than those before treatment (P<0. 05 or P<0. 01). And the counterpulsation group showed better results in the levels of LVEF, NYHA classification, 24-hour urine output, VO2max and AT compared to the control group, with significant differences (P<0.05 or P<0. 01). Conclusions EECP treatment is a relatively low-risk and non-invasive adjuvant therapy for elderly patients with chronic heart failure and renal insufficiency. It has short-term effects such as increasing urine output, improving heart function and benefiting cardiac rehabilitation.
References |
Related Articles |
Metrics
|